Protocol No.: AL46901-EAP

A MULTICENTER, OPEN-LABEL EXPANDED ACCESS PROGRAM TO PROVIDE GIREDESTRANT TO PATIENTS WITH ER+, HER2- EARLY OR METASTATIC BREAST CANCER
Principal Investigator
Jiang, Bei
Phase
NA
Age Group
Adult
Applicable Disease Site
Breast Cancer
Participating Institution
Mary Babb Randolph Cancer Center
Contact
Emily Hawkins, BSN
Research Nurse
Phone: +1 304-293-7375

View on ClinicalTrials.gov